Adipogenic Transcriptional Regulation of Hepatic Stellate Cells*

Hepatic stellate cells (HSC) undergo transdifferentiation (activation) from lipid-storing pericytes to myofibroblastic cells to participate in liver fibrogenesis. Our recent work demonstrates that depletion of peroxisome proliferator-activated receptor γ (PPARγ) constitutes one of the key molecular events for HSC activation and that ectopic expression of this nuclear receptor achieves the phenotypic reversal of activated HSC to the quiescent cells. The present study extends these findings to test a novel hypothesis that adipogenic transcriptional regulation is required for the maintenance of HSC quiescence. Comparative analysis of quiescent and activated HSC in culture reveals higher expression of putative adipogenic transcription factors such as CCAAT/enhancer-binding protein (C/EBP) α, C/EBPβ, C/EBPδ, PPARγ, liver X receptor α, sterol regulatory element-binding protein 1c and of adipocyte-specific genes in the quiescent cells. Conversely, activated HSC have increased expression of PPARβ, a transcription factor known to promote fatty acid oxidation. A treatment of activated HSC with the adipocyte differentiation mixture (isobutylmethylxanthine, dexamethasone, and insulin) or ectopic expression of PPARγ or SREBP-1c in these cells, induces a panel of adipogenic transcription factors, reduces PPARβ, and causes the phenotypic reversal to quiescent HSC. These results support the importance of adipogenic transcriptional regulation in HSC quiescence and provide a new framework for identifying novel molecular targets for the treatment of liver cirrhosis.

[1]  R. Evans,et al.  PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation , 2001, Nature Medicine.

[2]  B. Spiegelman,et al.  Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. , 1996, Molecular endocrinology.

[3]  Jong Bae Seo,et al.  Activated Liver X Receptors Stimulate Adipocyte Differentiation through Induction of Peroxisome Proliferator-Activated Receptor γ Expression , 2004, Molecular and Cellular Biology.

[4]  Y. Tintut,et al.  HOXB7 overexpression promotes differentiation of C3H10T1/2 cells to smooth muscle cells , 2000, Journal of cellular biochemistry.

[5]  Kozo Nakamura,et al.  PPARgamma insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors. , 2004, The Journal of clinical investigation.

[6]  Sumio Watanabe,et al.  Immunocytochemical Detection of Desmin in Fat‐Storing Cells (Ito Cells) , 1984, Hepatology.

[7]  R. Aebersold,et al.  Crucial Step in Cholesterol Homeostasis Sterols Promote Binding of SCAP to INSIG-1, a Membrane Protein that Facilitates Retention of SREBPs in ER , 2002, Cell.

[8]  T. Saibara,et al.  Immunohistochemical identification of Ito cells and their myofibroblastic transformation in adult human liver , 2004, Virchows Archiv.

[9]  R. Morrison,et al.  Hormonal signaling and transcriptional control of adipocyte differentiation. , 2000, The Journal of nutrition.

[10]  T. Roskams,et al.  Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors , 2001, Hepatology.

[11]  W. Wahli,et al.  PPARbeta regulates vitamin A metabolism-related gene expression in hepatic stellate cells undergoing activation. , 2003, Journal of lipid research.

[12]  A Geerts,et al.  History, Heterogeneity, Developmental Biology, and Functions of Quiescent Hepatic Stellate Cells , 2001, Seminars in liver disease.

[13]  O. Bezy,et al.  Transdifferentiation of preadipose cells into smooth muscle-like cells: role of aortic carboxypeptidase-like protein. , 2004, Experimental cell research.

[14]  S. Friedman,et al.  Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.

[15]  O. MacDougald,et al.  Transcriptional regulation of gene expression during adipocyte differentiation. , 1995, Annual review of biochemistry.

[16]  F. Weiner,et al.  Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha. , 1989, Biochemistry.

[17]  S. Friedman,et al.  Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. , 1998, The Journal of biological chemistry.

[18]  J. Goldstein,et al.  Insig-2, a second endoplasmic reticulum protein that binds SCAP and blocks export of sterol regulatory element-binding proteins , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  T. Veit,et al.  Expression of the gene of the α-smooth muscle-actin isoform in rat liver and in rat fat-storing (ITO) cells , 1990, Virchows Archiv. B, Cell pathology including molecular pathology.

[20]  T. Roskams,et al.  Synaptophysin: A novel marker for human and rat hepatic stellate cells. , 1999, The American journal of pathology.

[21]  D. Suskind,et al.  Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. , 2004, Journal of hepatology.

[22]  A. Diehl,et al.  Tumor necrosis factor-alpha stimulates the maturation of sterol regulatory element binding protein-1 in human hepatocytes through the action of neutral sphingomyelinase. , 1998, The Journal of biological chemistry.

[23]  R. Caporale,et al.  Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells. , 2000, Gastroenterology.

[24]  M. Brown,et al.  Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Crabb,et al.  Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. , 2002, Gastroenterology.

[26]  R. Walczak,et al.  Autoregulation of the Human Liver X Receptor α Promoter , 2001, Molecular and Cellular Biology.

[27]  R. Rippe,et al.  Peroxisome Proliferator-activated Receptor γ Induces a Phenotypic Switch from Activated to Quiescent Hepatic Stellate Cells* , 2004, Journal of Biological Chemistry.

[28]  W. Blaner,et al.  Biochemical characteristics of isolated rat liver stellate cells , 1987, Hepatology.

[29]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[30]  Jinping Li,et al.  Insig-1 “brakes” lipogenesis in adipocytes and inhibits differentiation of preadipocytes , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Tafuri,et al.  Regulation of Peroxisome Proliferator-activated Receptor γ Activity by Mitogen-activated Protein Kinase* , 1997, The Journal of Biological Chemistry.

[32]  Jean-Marc A. Lobaccaro,et al.  Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ , 2000 .

[33]  Hitoshi Shimano,et al.  Identification of Liver X Receptor-Retinoid X Receptor as an Activator of the Sterol Regulatory Element-Binding Protein 1c Gene Promoter , 2001, Molecular and Cellular Biology.

[34]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[35]  R. Derynck,et al.  Bone morphogenetic protein and retinoic acid signaling cooperate to induce osteoblast differentiation of preadipocytes , 2002, The Journal of cell biology.

[36]  B. Spiegelman,et al.  ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. , 1996, Genes & development.

[37]  U. Schibler,et al.  A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA , 1991, Cell.

[38]  T. Willson,et al.  Peroxisome Proliferator-activated Receptors and Hepatic Stellate Cell Activation* , 2000, The Journal of Biological Chemistry.

[39]  B. Spiegelman,et al.  Adipogenesis and Obesity: Rounding Out the Big Picture , 1996, Cell.

[40]  S. Afford,et al.  Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation. , 2000, The American journal of pathology.

[41]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[42]  Toshio Ito,et al.  Über die Kupfferschen Sternzellen und die “Fettspeicherungszellen” (“fat storing cells”) in der Blutkapillarenwand der menschlichen Leber. , 1952 .

[43]  M. Lazar,et al.  A Dominant-negative Peroxisome Proliferator-activated Receptor γ (PPARγ) Mutant Is a Constitutive Repressor and Inhibits PPARγ-mediated Adipogenesis* , 2000, The Journal of Biological Chemistry.

[44]  F. P. White,et al.  Extra-neural glial fibrillary acidic protein (GFAP) immunoreactivity in perisinusoidal stellate cells of rat liver , 1985, Journal of Neuroimmunology.